Matrix metalloprotease-1 inhibits and disrupts Enterococcus faecalis biofilms.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 09 08 2018
accepted: 17 12 2018
entrez: 12 1 2019
pubmed: 12 1 2019
medline: 1 10 2019
Statut: epublish

Résumé

Enterococcus faecalis is a major opportunistic pathogen that readily forms protective biofilms leading to chronic infections. Biofilms protect bacteria from detergent solutions, antimicrobial agents, environmental stress, and effectively make bacteria 10 to 1000-fold more resistant to antibiotic treatment. Extracellular proteins and polysaccharides are primary components of biofilms and play a key role in cell survival, microbial persistence, cellular interaction, and maturation of E. faecalis biofilms. Degradation of biofilm components by mammalian proteases is an effective antibiofilm strategy because proteases are known to degrade bacterial proteins leading to bacterial cell lysis and growth inhibition. Here, we show that human matrix metalloprotease-1 inhibits and disrupts E. faecalis biofilms. MMPs are cell-secreted zinc- and calcium-dependent proteases that degrade and regulate various structural components of the extracellular matrix. Human MMP1 is known to degrade type-1 collagen and can also cleave a wide range of substrates. We found that recombinant human MMP1 significantly inhibited and disrupted biofilms of vancomycin sensitive and vancomycin resistant E. faecalis strains. The mechanism of antibiofilm activity is speculated to be linked with bacterial growth inhibition and degradation of biofilm matrix proteins by MMP1. These findings suggest that human MMP1 can potentially be used as a potent antibiofilm agent against E. faecalis biofilms.

Identifiants

pubmed: 30633757
doi: 10.1371/journal.pone.0210218
pii: PONE-D-18-23570
pmc: PMC6329490
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Recombinant Proteins 0
Vancomycin 6Q205EH1VU
MMP1 protein, human EC 3.4.24.7
Matrix Metalloproteinase 1 EC 3.4.24.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0210218

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Antibiot (Tokyo). 2013 Feb;66(2):55-60
pubmed: 23149515
J Med Microbiol. 2007 Dec;56(Pt 12):1581-8
pubmed: 18033823
J Bacteriol. 2016 Sep 09;198(19):2579-88
pubmed: 27185827
Int J Food Microbiol. 2014 Sep 18;187:26-32
pubmed: 25043896
mBio. 2012 Jul 24;3(4):e00193-12
pubmed: 22829679
J Bacteriol. 2012 May;194(10):2677-86
pubmed: 22447899
Microbiol Mol Biol Rev. 2014 Sep;78(3):510-43
pubmed: 25184564
FEBS Open Bio. 2016 May 19;6(6):586-93
pubmed: 27419061
Jundishapur J Microbiol. 2015 Oct 24;8(10):e23349
pubmed: 26587208
Microbiologyopen. 2014 Dec;3(6):897-909
pubmed: 25257373
Antimicrob Agents Chemother. 1993 Dec;37(12):2618-21
pubmed: 8109925
Biofouling. 2008;24(1):11-22
pubmed: 18058451
Microbiol Mol Biol Rev. 2013 Mar;77(1):73-111
pubmed: 23471618
J Bacteriol. 2007 Nov;189(22):8233-40
pubmed: 17827282
Int J Artif Organs. 2005 Nov;28(11):1101-9
pubmed: 16353116
Appl Microbiol Biotechnol. 2007 May;75(1):125-32
pubmed: 17221196
J Bacteriol. 2001 Sep;183(18):5395-401
pubmed: 11514525
Infect Immun. 1981 Jul;33(1):212-22
pubmed: 6790441
Int J Med Microbiol. 2002 Jul;292(2):107-13
pubmed: 12195733
Sci Rep. 2017 Apr 07;7:46068
pubmed: 28387349
Food Funct. 2016 Sep 14;7(9):4030-4040
pubmed: 27722576
J Burn Care Rehabil. 1994 May-Jun;15(3):236-9
pubmed: 8056813
J Biol Chem. 2013 Oct 11;288(41):29440-52
pubmed: 23970550
J Biol Chem. 2001 Jun 22;276(25):22715-21
pubmed: 11410601
Protein Expr Purif. 2018 Aug;148:59-67
pubmed: 29626520
Int Endod J. 2014 Aug;47(8):756-68
pubmed: 24246147
Curr Biol. 2012 Jun 19;22(12):1047-56
pubmed: 22578418
Antimicrob Agents Chemother. 2001 Apr;45(4):999-1007
pubmed: 11257008
J Clin Microbiol. 2004 Jun;42(6):2548-57
pubmed: 15184433
Infect Immun. 1996 Mar;64(3):1035-8
pubmed: 8641755
Aust Dent J. 2015 Jun;60(2):143-53
pubmed: 25990488
Scand J Dent Res. 1989 Jun;97(3):233-41
pubmed: 2740834
Clin Infect Dis. 2001 Oct 15;33(8):1387-92
pubmed: 11565080
Biol Chem. 2011 Dec;392(12):1077-88
pubmed: 22050223
Nihon Saikingaku Zasshi. 2017;72(2):189-211
pubmed: 28659548
Infect Drug Resist. 2016 Apr 27;9:71-8
pubmed: 27175088
PLoS One. 2010 Dec 30;5(12):e15798
pubmed: 21209892
Acta Odontol Latinoam. 2015 Dec;28(3):210-4
pubmed: 27095620
J Bacteriol. 2004 Sep;186(17):5629-39
pubmed: 15317767
Fitoterapia. 2013 Oct;90:73-8
pubmed: 23831483
Science. 1998 Apr 10;280(5361):295-8
pubmed: 9535661
Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33
pubmed: 17318226
J Vis Exp. 2011 Jan 30;(47):
pubmed: 21307833
J Bacteriol. 2007 Dec;189(24):8835-43
pubmed: 17921295
Mikrobiyol Bul. 2011 Jul;45(3):430-45
pubmed: 21935776
Mol Microbiol. 2010 Feb;75(4):815-26
pubmed: 19602146
Sci Rep. 2016 Aug 05;6:31098
pubmed: 27492542
Antimicrob Agents Chemother. 2007 Aug;51(8):2733-40
pubmed: 17548491
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8436-41
pubmed: 27402741
J Antimicrob Chemother. 1994 Dec;34(6):885-97
pubmed: 7730232
Am J Obstet Gynecol. 2007 Aug;197(2):170.e1-7
pubmed: 17689638
FEMS Microbiol Rev. 2017 May 1;41(3):276-301
pubmed: 28369412
J Mol Biol. 2008 May 9;378(4):840-51
pubmed: 18402979
Oral Microbiol Immunol. 1994 Aug;9(4):224-8
pubmed: 7478762
J Biol Chem. 2013 Mar 29;288(13):8785-93
pubmed: 23430258
BMC Genomics. 2011 Mar 01;12:135
pubmed: 21362161
mBio. 2014 Oct 14;5(5):e01341-14
pubmed: 25316695
Lett Appl Microbiol. 2014 Nov;59(5):507-13
pubmed: 25041576
Biochim Biophys Acta. 2014 Aug;1840(8):2571-80
pubmed: 24631662
Microbiol Spectr. 2016 Apr;4(2):
pubmed: 27227291
Microbiol Spectr. 2015 Jun;3(3):
pubmed: 26185074
Curr Opin Pharmacol. 2013 Oct;13(5):699-706
pubmed: 23871261
APMIS. 2006 Feb;114(2):131-8
pubmed: 16519750
Biotechnol Lett. 2012 Apr;34(4):655-61
pubmed: 22160331
Lancet Infect Dis. 2001 Dec;1(5):314-25
pubmed: 11871804
J Endod. 2006 Jun;32(6):527-31
pubmed: 16728243
Infect Immun. 2004 Oct;72(10):6032-9
pubmed: 15385507
Clin Exp Immunol. 2005 Oct;142(1):12-20
pubmed: 16178851
Medicine (Baltimore). 2007 Nov;86(6):363-77
pubmed: 18004181
Curr Opin Cell Biol. 2001 Oct;13(5):534-40
pubmed: 11544020
Science. 2004 Oct 1;306(5693):108-11
pubmed: 15459390
Microbiol Spectr. 2015 Jun;3(3):
pubmed: 26185072
Appl Environ Microbiol. 1990 Jun;56(6):1875-81
pubmed: 16348228

Auteurs

Lokender Kumar (L)

Department of Physics, Colorado School of Mines, CO, United States of America.

Christopher R Cox (CR)

Department of Chemistry, Colorado School of Mines, CO, United States of America.

Susanta K Sarkar (SK)

Department of Physics, Colorado School of Mines, CO, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH